Abstract
Triple negative breast cancer (TNBC) is an aggressive neoplasm characterized by the non-expression of estrogen receptor and progesterone as well as the lack of expression of the HER2 gene. Currently, treatment is based on chemotherapy followed by surgery, where 50% of patients achieve complete recovery, while in the group of patients who do not respond, is noted a tumor progression with a…